Racial Disparities in COVID-19: Social Determinants of Health Equity

Physicians Committee for Responsible Medicine

E. Price-Haywood

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

Nutrition + Supplements in Cancer: Do's and Don'ts

Scripps Health

D. Abrams

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

Nutrition Oncology: A New Frontier

UCLA Health

M. Garcia

Could We Cure Metastatic Breast Cancer?

International Congress on Cancer Metastasis

L. Pusztai

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

C. Jackson

Basic Principles of Tumor Immunology

European School of Oncology

M. van den Broek

Characterizing the Immune Microenvironments of Brain Metastases

MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

P. Siegel

2024 Update in Oncologic Emergencies

UNC Lineberger Comprehensive Cancer Center

J. Stein

Bispecific vs. Combination Therapy - PRO Combination Therapy

ImmunoTherapy Bridge 2023

A. Patnaik

Bispecific vs. Combination Therapy - PRO Bispecific

ImmunoTherapy Bridge 2023

J. Gulley

Geriatric Oncology Updates: Guidelines and Priorities for Older Pati…

OncoAlert

L. Decoster

Innovating Immunotherapy for Pancreatic Cancer

ImmunoTherapy Bridge 2023

G. Lesinski

Novel Insights Into the Mechanisms of Radiation-Induced Anti-Tumor I…

ImmunoTherapy Bridge 2023

S. Demaria

Natural Medicines in Cancer Survivorship Care

Scripps Health

D. Leopold

Lymphocytes as a "Living Drug" for the Treatment of Cancer

Yale Cancer Center

S. Rosenberg

Tumor Immune Microenvironment and Immunotherapy Resistance

MI&T Congressi

D. Sangiolo

Immunotherapy for HCC: Current Status & Future Perspectives

ImmunoTherapy Bridge 2023

P. Federico